Naba Alsaha Medical Services Company

9546.SRSAUHealthcare● Active

$22.85

+$0.45(+2.01%)

Market Cap$479850000

P/E Ratio—

52W High$34.65

52W Low$20.37

Avg Volume5K

Open$22.99

Beta-0.44

Cash on Hand Financials Revenue

Naba Alsaha Medical Services Company (9546.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

9546.SR · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$19.0M▼ -55.6% vs prior year

FY · as of Dec 31, 2025 · Reported in SAR

Cash & Cash Equiv. (CCE)

$19.0M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-55.6%

vs prior fiscal year

Latest Quarter

$19.0M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$19.0MCash on Hand

Total Debt$122.8MTotal Debt

Net Cash / Net Debt−$103.8MNet Debt Position

Cash vs Debt Ratio

Cash 13%Naba Alsaha Medical Services Company cash as % of market cap: 3.96%% · MCap $0BDebt 87%

Naba Alsaha Medical Services Company carries a net debt position of $103.8M. Total debt ($122.8M) exceeds cash on hand ($19.0M). Naba Alsaha Medical Services Company cash vs debt ratio: 13% cash / 87% debt.

Net Cash = Cash & ST Investments − Total Debt$19.0M − $122.8M = −$103.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

9546.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

9546.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$19.0M-55.6%

Dec 31, 2024FY$42.8M+644.6%

Dec 31, 2023FY$5.7M-58.4%

Dec 31, 2022FY$13.8M+97.7%

Dec 31, 2021FY$7.0M+291.7%

9546.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

9546.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Naba Alsaha Medical Services CompanyYOU

9546.SR

$19.0M$480M4.0%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Naba Alsaha Medical Services Company (9546.SR) cash on hand as of December 31, 2025 is $19.0M, comprising $19.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Naba Alsaha Medical Services Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Naba Alsaha Medical Services Company cash reserves or cash position.

Naba Alsaha Medical Services Company annual cash on hand history shows decreased -55.6% in 2025: decreased -55.6% in 2025. Naba Alsaha Medical Services Company cash reserves in 2025 reflect the company's capital allocation strategy.

Naba Alsaha Medical Services Company carries total debt of $122.8M against cash of $19.0M, resulting in a net debt position of -$103.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

9546.SR cash on hand · 5 questions

As of December 31, 2025, Naba Alsaha Medical Services Company (9546.SR) has $18,990,205 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $18,990,205 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $18,990,205. Data sourced from the annual 10-K filing via FMP.

9546.SR cash on hand9546.SR cash reserves9546.SR cash 2025how much cash does 9546.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Naba Alsaha Medical Services Company · Naba Alsaha Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025